Orgenesis Inc

ORGS NASDAQ
4.440
-0.110
-2.42%
休市 16:00 08/23 EDT
开盘
4.470
昨收
4.550
最高
4.540
最低
4.372
成交量
4,187
成交均量(3M)
2.44万
52周最高
9.25
52周最低
3.780
换手率
0.03%
市值
7,166.59万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Orgenesis Inc ORGS股票价格,Orgenesis Inc股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products. MaSTherCell is providing two types of services to its customers: process and assay development services and good manufacturing practice (GMP) contract manufacturing services. The CTB activity is based on its technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating (converting) them into pancreatic beta cell-like insulin producing cells for patients with Type I Diabetes. It intends to advance a product that combines cell-based therapy and regenerative medicine, Autologous Insulin Producing (AIP) cells, into clinical development.
展开 >

最近浏览

名称
价格
涨跌幅